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Abstract The control of human ribosomal protein L22 (rpL22)
to enter into the nucleolus and its ability to be assembled into the
ribosome is regulated by its sequence. The nuclear import of
rpL22 depends on a classical nuclear localization signal of four
lysines at positions 13^16. RpL22 normally enters the nucleolus
via a compulsory sequence of KKYLKK (I-domain, positions 88^
93). An acidic residue cluster at the C-terminal end (C-domain)
plays a nuclear retention role. The retention is concealed by the
N-domain (positions 1^9) which weakly interacts with the C-
domain as demonstrated in the yeast two-hybrid system. Once it
reaches the nucleolus, the question of whether rpL22 is assembled
into the ribosome depends upon the presence of the N-domain.
This suggests that the N-domain, on dissociation from its
interaction with the C-domain, binds to a specific region of the
28S rRNA for ribosome assembly. ß 2000 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
The paradigm by which proteins are imported to the nu-
cleus from the cytoplasm has been established [1^3]. Despite
the fact that there is no precise consensus amino acid sequence
for nuclear localization [4], the principles governing protein
importation to the nucleus are well understood [5]. In con-
trast, little is known about the signal that directs a protein to
the nucleolus after the protein enters the nucleus. The nucle-
olus contains many proteins and RNA molecules that partic-
ipate in important functions in a eukaryotic cell [6]. The nu-
cleolus is also the site of ribosome biogenesis and is where the
ribosomal RNA interacts with the imported ribosomal pro-
teins to make the pre-ribosomal particle [6]. Ribosomal pro-
teins, like other nuclear proteins, are synthesized in the cyto-
plasm and are then required to pass through the nuclear pores
[3] and nucleoplasm on their way to the nucleolus for the
completion of ribosome assembly. Hence, the movement of
ribosomal protein in the cellular compartment becomes a
unique and attractive system for the study of the mechanism
behind nuclear and nucleolar transportation.
It has been assumed that each ribosomal protein carries the
signal sequence necessary for nuclear and nucleolar targeting
[7,8]. Examination of the primary sequences of all eukaryotic
ribosomal proteins available [9] allowed the tentative identi¢-
cation of the nuclear localization signal (NLS) of ribosomal
proteins, the known consensus NLS [9]. Either a classic basic
cluster sequence or a basic bipartite sequence [4] is commonly
found with few exceptions in the sequences of most eukaryotic
ribosomal protein [9]. On the other hand, identi¢cation of the
nucleolar targeting sequence (NoS) of ribosomal proteins has
not been reported. A few potential sequence motifs have been
documented [8,10^15], but these lack a consensus sequence for
the nucleolar targeting common to the ribosomal proteins or
other nucleolar proteins [16^22].
In this report, we have attempted to identify the sequence
that targets a ribosomal protein to the nucleolus and thence
into the ribosome. As the ¢rst step in determining the mode of
nucleolar entry, a human ribosomal protein L22 (rpL22) was
selected because it contains three distinct structures [22]. The
other reason for choosing rpL22 for this study, besides it
being an intrinsic component of ribosome, is that rpL22 is
known to be multi-functional. In a previous study, rpL22
was identi¢ed as EAP (the Epstein-Barr virus-encoded small
nuclear RNA-associated protein) [23^25]. Subsequently,
rpL22 was also found to be associated with the herpes simplex
virus (HSV) regulatory proteins ICP-4 and ICP-22 [26^29].
These viral proteins are known to be involved in the tran-
scription of the viral early genes in the nucleus. The presence
of rpL22 regulates the expression of these viral early genes.
Thus, the elucidation of the mechanism by which rpL22 tar-
gets the nucleus and shuttles itself between the nucleoplasm
and nucleolus could help in understanding the important
question as to how a cellular ribosomal protein possibly af-
fects the activity of a virus in an infected cell.
2. Materials and methods
2.1. Plasmids, primers and polymerase chain reaction (PCR)
The gene coding for human rpL22 was obtained from the human
liver cDNA library (kind gift of Dr. Peter Hsai, Institute of Genetics,
National Yang-Ming University, Taiwan). It was ampli¢ed by PCR
using primers identi¢ed from the published sequences of rat liver
rpL22 (GenBank accession No. X78444) [23]. The primers were
5P-catatggctcctgtgaaaaa-3P (the N-primer, the sequence underlined
was modi¢ed to create an NdeI site) and 5P-gaattctaatcctcgtcttcc-3
(the C-primer, the sequence underlined was modi¢ed to create an
EcoRI site). The PCR fragment was subsequently inserted into the
vector pGEM-T to make the plasmid pGEM-T/rpL22. The plasmid
pGEN-T/rpL22 was used as the template for constructions of wild
type rpL22 and its truncated mutants which were inserted into the
eukaryotic expression plasmid (pFLAG-CMV-2) (Eastman Kodak
Co.) using a similar PCR strategy. These recombinant plasmids car-
ried a CMV promoter and rpL22 gene or its mutant genes and these
were tagged by a £ag peptide at the amino terminal end of the coding
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sequence. The recombinant plasmids were prepared and transfected
into HeLa cells to study the sub-cellular localization of the expressed
recombinant proteins. All constructions have been veri¢ed by DNA
sequencing.
2.2. Cell cultures and DNA transfection
HeLa cells were cultured in Dulbecco’s modi¢ed Eagle’s medium
(Life Technologies) supplemented with 10% fetal calf serum (Life
Technologies), 5 mM L-glutamine, 50 Wg/ml streptomycin and 50
U/ml penicillin. Cells were seeded onto coverslips in a 60 mm petri
dish. Eighteen h after plating, plasmid transfection was carried out by
the calcium phosphate precipitation method. Ten Wg of plasmid was
used for each transfection. At di¡erent times of post-transfection, the
coverslips were processed for indirect immuno£uorescence staining,
and examined using a confocal microscopy.
2.3. Confocal immuno£uorescence microscopy
Cells grown on a coverslip were ¢xed at di¡erent times post-trans-
fection with 3.7% formaldehyde in phosphate bu¡ered saline (PBS),
kept for 20 min at room temperature and then permeabilized in 0.1%
Triton X-100 in PBS for 5 min. The coverslip was then incubated for
15 min at room temperature with a mouse monoclonal antiserum anti-
£ag peptide (M2, Eastman Kodak Co.). The antiserum was used at a
1:500 dilution in PBS containing 0.2% gelatin. The coverslip was
washed with PBS containing 0.2% gelatin solution and then incubated
for 15 min at room temperature with the £uorochrome conjugated
secondary antibody. As the secondary antibody, an anti-mouse IgG
(Fc-speci¢c) conjugated with £uorescein isothiocyanate (FITC; East-
man Kodak Co.) was used at 1/500 dilution in PBS containing 2%
gelatin. The coverslip was washed several times with PBS containing
0.2% gelatin and then mounted with Mowiol on a microscope slide.
The cells were analyzed on a Leicas confocal microscope (model
TCSNT) using 450^490 nm £uorescent ¢lters.
2.4. Yeast two-hybrid system
A reporter yeast strain was co-transformed with pAS2-1 (DNA BD
plasmid) and pACT2 (AD plasmid) (Clontech Lab., USA). Two trun-
cated rpL22 mutants were constructed for the two-hybrid system to
detect the possible interaction between the N-domain and the C-do-
main of rpL22. One carried the ¢rst 87 residues of rpL22 (N87), and
the other carried the last 65 amino acid residues (C65). These two
clones were constructed by the same strategy of PCR ampli¢cation
using pGEM-T/rpL22 as the template. The two clones, along with the
gene coded for rpL22, and the genes encoding two other truncated
rpL22 mutant genes (vN9 and vC8) were separately placed into
DNA-BD plasmid (pAS2-1), and the GAL4 AD plasmid (pACT2).
The recombinant plasmids were co-transformed into a reporter yeast
strain (Y187 and CG1945) that possessed the His3 and LacZ genes
under control of a GAL4 responsive element. The co-transformants
were streaked on medium containing SD/3His/3Leu/3Trp/+5 mM
3-AT to assay for activation of the L-galactosidase reporter gene. The
procedures for yeast cell transformation, growth in the selective me-
dium and the L-galactosidase activity, including the o-nitrophenyl L-D-
galactopyranoside (ONPG) assay for the measurement of the activity
of L-galactosidase, followed those recommended in the Matchmaker
system handbook (PT3024-1, Clontech Lab., USA).
2.5. Preparation of recombinant ribosomes and immunological ribosome
dot blotting
HeLa cells were transfected by the di¡erent eukaryotic expression
plasmids containing the wild type rpL22 gene or the truncated rpL22
genes. Twenty one h post-transfection, cells (1U107 cells) were broken
by sonication in T20K50M12:5 bu¡er (20 mM Tris^HCl, pH 7.6;
50 mM KCl; 12.5 mM MgCl2 in 0.25 M sucrose. Ribosomes were
prepared from cell lysate by di¡erential centrifugation as described
previously [30]. These ribosomes were made up of the ribosomes
from non-transfected HeLa cells, the endogenous ribosomes from
transfected HeLa cells, and the recombinant ribosomes that contained
the recombinant rpL22 or the truncated mutant proteins if these re-
combinant proteins had been incorporated into ribosomes. To exam-
ine the presence of recombinant protein in the prepared ribosomes,
total ribosomal proteins were extracted with 67% acetic acid and
analyzed by Western blot using the anti-£ag peptide antibody.
The ribosome immuno dot blotting assay [31] was used to deter-
mine the surface exposure of recombinant protein on the ribosome. In
brief, one OD260 unit of prepared ribosomes in 20 Wl of T20K50M5
bu¡er (20 mM Tris^HCl, pH 7.6; 50 mM KCl and 5 mM MgCl2) was
dotted on nitrocellulose paper. The nitrocellulose was blocked with
bovine serum albumin and washed before being reacted with the anti-
£ag peptide antibody. Ribosomes that bound the anti-£ag peptide
antibodies were detected by a non-radioactive AP^biotin^avidin
chromogen (Bio-Rad Co., USA).
3. Results
3.1. Construction and expression of genes coded for rpL22 and
its mutants
The truncated mutant proteins of rpL22 were designed ac-
cording to the characteristics of the primary structure of
rpL22 (Fig. 1A,B) which shows the N-domain, the I-domain
and the C-domain. These genes were cloned into eukaryotic
expression vectors (pFLAG-CMV-rpL22). The expression of
these genes in 21 h transfected HeLa cells was examined, and
found to be quantitatively and qualitatively sound (Fig. 1C).
3.2. Sub-cellular localization of the £ag tag proteins containing
rpL22 and its mutant proteins
By indirect immuno£uorescence with an anti-£ag peptide
antibody, the recombinant £ag tagged rpL22 protein was lo-
cated in the nucleolus of host HeLa cells (Fig. 2A). In the
control, HeLa cells that carried only the £ag peptide vector
did not show any immuno£uorescence. Following this, under
the same conditions, the sub-cellular locations of transiently
expressed deletion mutant proteins were examined. This
showed that mutant protein vC8 was located in the nucleolus
(Fig. 2B), but the mutant proteins that lacked the N-domain
(vN9) remained in nucleoplasm (Fig. 2C). However, on dele-
tion of both domains, the mutant protein (vN9/C8) entered
the nucleolus (Fig. 2D). These results indicated that nucleolar
entry of rpL22 must be controlled by both its N- and
C-terminal regions.
By analysis of the amino acid sequence motifs of known
nuclear or nucleolar targeting signals [4,9], it was determined
that the protein rpL22 carried two potential signals, one
around the N-domain and the other at the internal region
(I-domain) (Fig. 1A). In order to de¢ne the possible involve-
ment of these two regions in sub-cellular localization, indirect
immuno£uorescent localization with anti-£ag antibody was
carried out again with deletion mutants of vN15, vN15/C8
and v88^93. These results showed that the proteins without
the ¢rst 15 residues at the NH2-terminal end (vN15, or vN15/
C8) resulted in a cytoplasmic rpL22 (Fig. 2E,F), implying that
the sequence of KKKK (positions 10^14) was the NLS. More-
over, mutant protein v88^93 was retained in the nucleoplasm
(Fig. 2G), suggesting that sequence KKYLKK (positions 88^
93) was needed for nucleolar entry of rpL22.
3.3. Interaction between the N-domain and C-domain detected
by the yeast two-hybrid system
The two-hybrid system was employed to study the possible
interaction between the N-domain and the C-domain involved
in entry into the nucleolus. Two deletion mutants were created
speci¢cally for this system. Mutant N87 carried only the ¢rst
87 amino acid residues of rpL22 and mutant C65 contained
only the last 65 amino acid residues from its carboxyl termi-
nus. Strains expressing both Lex-N87 and GAD-vN9 or Lex-
C65 and GAD-C8 activated L-galactosidase expression of a
LexAop-GAL-LacZ reporter gene (Fig. 3A). Activation de-
pends on the presence of both the N- and C-domain because
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no activation was detected in the absence of either in the
fusion proteins when expressed in combination with LexA
or GAD (data not shown).
The results of the yeast two-hybrid system (Fig. 3A) indi-
cated that the mutant N87 reacted positively to wild type L22
and vN9 (having the C-domain), but failed to react when N87
gene was used as either the donor or as the acceptor in the
two-hybrid system (Fig. 3A). Similarly, mutant C65 was ca-
pable of interacting with vC8 (carrying the N-domain), but
did not undergo self-interaction (Fig. 3A). The L-galactosi-
dase activity was then measured by the ONPG assay (Fig.
3B). This result showed that the L-galactosidase activity due
to the interaction between the N- and C-domain increased 3^
4-fold when compared to the measurable L-galactosidase ac-
tivity of a hybrid without either domain, suggesting that the
N- and C-domain interaction was weak.
3.4. Assembly of rpL22 into ribosome
To see whether the recombinant £ag tagged rpL22 or its
mutant proteins after reaching the nucleolus were capable of
being assembled into ribosomes, the recombinant £ag tagged
rpL22 was detected in prepared ribosomes using anti-£ag pep-
tide antibody. Also, the possible exposure of recombinant
protein on the surface of ribosome particle was examined
using a ribosome dot blot assay [31]. Ribosomes were pre-
pared from 21 h post-transfection cells that had been trans-
fected with the plasmid carrying the £ag tagged rpL22 genes.
These ribosomes comprised of native ribosomes from non-
transfected HeLa cells plus native ribosomes from transfected
HeLa cells and recombinant ribosomes which had incorpo-
rated the transiently expressed £ag tagged rpL22. The ribo-
some dot blotting showed that the prepared mixed ribosomes
from transfected cells immunologically reacted with the anti-
body (Fig. 4A), whereas ribosomes (wild type ribosomes) sep-
arately prepared from non-transfected HeLa cells did not
(Fig. 4A). Using the same dot blot assay, the ribosomes pre-
pared from HeLa cells that had been transfected with the
di¡erent mutant genes of rpL22 were tested. The results
(Fig. 4A) showed that the mutants of vN15, v88^93 (ID)
and vN9/C8 produced negative results, while vC8 was posi-
tive. The negative ¢ndings for mutants of vN15 and v88^93
are understandable since these proteins have been shown to be
unable to reach the nucleolus (Fig. 2G). However, the failure
of mutant vN9/C8 to be incorporated into ribosomes was
surprising because the protein was transported to the nucleo-
lus (Fig. 2C). One possible reason was that the £ag tag pep-
tide of recombinant proteins was inaccessible to the antibody
in assembled ribosomes. Therefore, we examined the presence
of the recombinant mutant protein (vN9/C8) in a total ribo-
somal protein extract carried out by Western blotting using
the anti-£ag peptide antibody. The results as given in Fig. 4B
showed that the recombinant vN9/C8 protein could not be
detected, even when the amount of total ribosomal proteins
was overloaded, supporting the fact that the vN9/C8 mutant
protein was incapable of incorporation into ribosomes. In
contrast, the recombinant wild type or the vC8 mutant pro-
teins were incorporated into the ribosomes (Fig. 4B).
4. Discussion
rpL22 contains three distinct domains, namely, the N-do-
main, the I-domain and the C-domain (Fig. 1A). The N-do-
main is made up of the ¢rst nine amino acid residues at the
NH2-terminal end, and is hydrophobic in nature. The I-do-
main (positions 80^93) includes two basic cluster repeats of
KKYLK. The C-domain (positions 120^128) is a stretch of
nine acidic amino acid that is found in many nucleolar
Fig. 1. Analysis of the expressed recombinant protein rpL22.
A: The alignment of the primary structure of rpL22 with its homo-
logous ribosomal proteins from other species and other related pro-
teins. Regions of interest are indicated by a double arrowhead and
marked ‘N-domain’, ‘I-domain’ and ‘C-domain’. XENL, Xenopus
laevis ; GRDM, ¢sh; TRIGR, sea urchin; CAEE, Caenorhabditis
elegans ; YEAS, Saccharomyces cerevisiae ; HPp15, heparin binding
protein 15. B: Schematic representation of rpL22 and its truncated
mutants. The ¢lled bar represents the sequence that carries the £ag
peptide. The open bars are the remaining portions (as indicated by
number) of rpL22. vN9 (a mutant rpL22 with nine residues deleted
from its amino terminal end); vN15 (a mutant rpL22 with 15 resi-
dues deleted from its amino terminal end); vC8 (a mutant rpL22
with eight residues deleted from its carboxyl terminal end); vN9/C8
(a mutant rpL22 with the nine and eight residues deleted from the
amino terminal and the carboxyl end, respectively); vN15/C8 (a
mutant rpL22 with the 15 and eight residues deleted from the ami-
no terminal and the carboxyl end, respectively); v88^93 (a deletion
of the I-domain which has lost amino acids 80^93). C: The expres-
sion of recombinant protein detected by Western blotting using an
anti-£ag peptide antibody. Analysis was done on a total cell lysate
of HeLa cells that had been transfected with the vector for 21 h.
Equal cell numbers (1.5U107 cells) were analyzed by sodium dodec-
yl sulfate-containing 15% polyacrylamide gel electrophoresis.
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Fig. 2. Immuno£uorescent localization of £ag tagged rpL22 and its truncated mutant proteins. Expression of recombinant rpL22 and its trun-
cated mutant proteins in HeLa cells transfected with the pCMV-promoter plasmids which carry the rpL22 gene and its mutant genes. After 21
h, the position of the expression of recombinant proteins rpL22 (A), vC8 (B), vN9 (C), vN9/C8 (D), vN15 (E), vN15/C8 (F), v88^93 (G)
were located in the HeLa cells by indirect immuno£uorescence using an anti-£ag peptide antibody. The immunostaining was carried out by a
second antibody, FITC-conjugated anti-mouse IgG antibody.
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proteins [6,19,22,32]. The importance of these domains in the
targeting of the protein to the nucleus or the nucleolus and in
the assembly of the ribosome is the focal point of this study.
The indirect immuno£uorescent microscopy study con¢rms
that the basic KKKK (residues 13^16) positioned near the N-
domain is the sequence responsible for nuclear entry of rpL22.
This basic cluster is similar to the known consensus NLS
[8,36], and the determined NLS of the ribosomal protein S7
[10]. The same experiments showed that the KKYLKK se-
quence (positions 88^93) in the I-domain was a necessary se-
quence for nucleolar entry of rpL22 since the deletion of this
sequence resulted in nucleoplasmic rpL22 (Fig. 2G). The
KKYLK sequence is repeated twice at the I-domain (KRYLK
at positions 80^84) of the protein. Such a repeated sequence
cannot be found in other eukaryotic ribosomal proteins (un-
published survey). An attempt to fuse the I-domain to green
£uorescent protein to test for nucleolar entry failed (data not
shown), suggesting that more than one sequence is needed for
a cooperative nucleolar entry as suggested by another study
[2].
Besides requiring the sequence KKYLKK, nucleolar entry
of rpL22 may be regulated by an interaction between the
N-domain and the C-domain. This is suggested because a
protein without the N-domain became a nucleoplasmic pro-
tein, while a protein without both N- and C-domain does
reach the nucleolus (Fig. 2D). These observations suggest
that the acidic amino acid cluster may carry a nuclear reten-
tion role, and the regulation of such a retention role may
depend upon its interaction with the N-domain. The yeast
two-hybrid system con¢rmed the existence of the N- and
C-domain interaction. However, because of the low level of
L-galactosidase activity tested, we suggested that the contact
between the N-domain and C-domain is weak but would seem
to be su⁄cient to mask the nuclear retention e¡ect of the
C-domain.
The question needs to be proposed as to why a protein
Fig. 3. The interaction between the N-domain and the C-domain in
the yeast two-hybrid system. The mutant genes N87 and C67 along
with the genes coded for wild type rpL22, vN9 and vC8, were
placed separately into DNA-BD plasmid (pAS2^1) and GAL4 AD
plasmid (pACT2). The recombinant plasmids were co-transformed
into a reporter yeast strain (Y187 and CG1945), which possessed
the His3 and LacZ genes under the control of a GAL4 responsive
element. Co-transformants were streaked on SD/3His/3Leu/3Trp/
+5 mM 3-AT to assay for the activation of the L-galactosidase re-
porter gene. A: The panels present the interaction of (a) N87: :wild
type rpL22; (b) N87: :vN9; (c) C65: :vC8; (d) N87: :C65; (e)
N87: :N87 and (f) C65: :C65. The profuse growth in (a), (b), (c) and
(d) indicated that these co-transformants contained interacting hy-
brid plasmids. B: The level of expression of L-galactosidase that
was measured by the ONPG assay. These measurements indicated
that the activity of L-galactosidase found in hybrids of N87-rpL22,
N87-vN9, C65-vC8 and N87-C65 was increased 3^4-fold as com-
pared with hybrids of N87: :N87 or C65: :C65.
Fig. 4. Ribosome dot blotting analysis of the assembly of rpL22
into ribosomes. A: The detection of the incorporation of £ag tagged
rpL22 in ribosomes by dot blot assay. The assay detects ribosomes
with a surface £ag tagged recombinant protein. Each dot contains
one OD260 unit of ribosomes that were isolated from a 21 h post-
transfection HeLa cell. The nucleolar entry of each expressed re-
combinant protein is shown by markers of + (for the positive), and
3 (for the negative). ID represents mutant of v88^93. B: The West-
ern blot of total protein extract from ribosomes 21 h post-trans-
fected HeLa cells. The results from (A) and (B) were visualized by
the immuno-cross-reactivity using the anti-£ag peptide antibody.
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needs two regulating elements to enter the nucleolus. One
possible clue could be the dual function of rpL22 and its
importance in viral infected cells. In recent studies, the host
EAP protein that regulates the transcription of the early gene
of EBV was identi¢ed to be the rpL22 [9,24]. Ironically, rpL22
was lately shown to be related to the major regulatory viral
proteins of ICP4 or ICP22 of HSV [26^28]. There are reports
that rpL22 participated with these regulatory proteins in the
expression of early genes of HSV. Under these circumstances,
it is reasonable to suggest that nuclear retention of rpL22
could be an inevitable step in virus-infected cells. Thus, break-
ing the weak interaction between the two domains would
make rpL22 nucleoplasmic and available for transcription of
the viral gene. The necessary role of an acidic cluster in the
shuttling of rpL22 between nucleus and nucleoli is obvious.
It is noticeable that many nucleolar proteins, such as SSB-1
[6], Nop2 [30], NOP77p [32], p120 [21] and NOP4 [33] contain
an acidic amino acid cluster. These proteins are known to be
involved in the interaction of the ribosomal components dur-
ing the ribosome biogenesis. Trapping by the ¢ne structure of
the nucleolus in order to retain these proteins has been sug-
gested, but the role of the acidic amino acid cluster in these
proteins has never been revealed. It can only be speculated
that their acidic clusters are masked to allow these proteins to
move into the nucleolus. In this study, we have assumed that
the acidic cluster plays the same role of nuclear retention for
rpL22, that is, it helps a nucleolar protein remain in the nu-
cleus. This is also true for several nucleic acid associated pro-
teins, such as heparin binding protein (HBp15) [34], the DNA
binding protein of the high mobility group [35], and the tran-
scription activator of Tat-SF1 [36]. These proteins which are
retained in the nucleus characteristically carried a stretch of
acidic clusters at their carboxyl-terminal region. Although, the
role that the acidic cluster plays in these proteins has not been
studied in detail, the same nuclear retention role is suggested.
A similar acidic amino acid cluster has been found in the
structure of several eukaryotic proteins, namely L5, L31, P0,
P1, P2, S8 and S9 (range of four to eight acidic residues) [9].
Whether these clusters play the same role needs to be studied.
In fact, it may be more important if these ribosomal proteins
have a dual function, a reality for these members of eukary-
otic ribosomal proteins [9].
In this study, we posed the question as to whether the
transiently expressed recombinant £ag tagged ribosomal
protein can be successfully assembled into ribosomes. We
detected the recombinant £ag tagged protein in isolated
ribosomes. The detection relied on the immuno-reactivity be-
tween the £ag tagged recombinant protein and the anti-£ag
peptide antibody. We also detected, using ribosome dot
blotting [31], whether the £ag tag peptide was on the outside
of the ribosome particles and detected by Western blotting if
the recombinant proteins were part of the total ribosomal
proteins. In both assays, the recombinant £ag tagged rpL22
was found to be present, indicating that the recombinant
protein has successfully incorporated into ribosomes. Under
such conditions, the mutant protein, without the C-domain
(lacking of acidic cluster) which allowed it to reach the nucle-
olus, was also found in the ribosome. However, the mutant
protein without both the N- and the C-domains could reach
the nucleolus but was not assembled into ribosomes. These
results clearly show that the binding of the N-domain to 28S
rRNA is a prerequisite for rpL22 to be assembled into the
ribosomes. In a previous study [25], the nucleotide sequence
from 302 to 317 of the 28S rRNA was found to be the binding
site for rpL22. Thus, it should be expected that the interaction
takes place between this nucleotide segment and the eight
amino acid residues from the N-domain. The interaction
should be strong enough to compete with the weak associa-
tion of the N-domain and the C-domain once rpL22 enters
the nucleolus. It can also be speculated that a similar compe-
tition might occur in the nucleoplasm when the cell is infected
with virus. This needs to be determined.
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